Acidophil utilizes applied genetics, synthetic biology, synthetic chemistry, bio-chemical engineering and information technology to optimize the discovery and development of novel compounds and related production processes for agricultural, industrial, animal and human healthcare applications.
Alexandria Real Estate Equities, Inc. (Alexandria Venture Investments)
Alexandria Real Estate Equities, Inc. (NYSE:ARE) is an urban office REIT uniquely focused on world-class collaborative science and technology campuses in AAA innovation cluster locations, with a total market capitalization of $13.0 billion and an asset base in North America of 24.5 million square feet as of September 30, 2016. The asset base in North America includes 18.8 million RSF of operating properties and development and redevelopment projects (under construction of pre-construction) and 5.7 million square feet of future ground-up development projects. Alexandria pioneered this niche in 1994 and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle Park.
Anterra Capital is a specialist venture capital investor dedicated to financing the growth of companies operating in the food & agricultural sectors. We invest across the food supply chain in technology driven companies. Our fast growing portfolio is changing the way that global food supply chains operate. Enabling them to be safer, more efficient, and ultimately more sustainable.
RA Capital Management
RA Capital Management® (“RA Capital”) is a crossover investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with fewer capital concerns from inception through commercialization.
Syngenta Ventures is the venture capital arm of Syngenta AG. They invest in early-stage companies that have the potential to help growers around the world farm more productively. As one of the most active investors in agriculture they have invested over US$100m since 2006. Their mission is to accelerate the rate of innovation in agriculture to support Syngenta’s vision of increasing farm productivity by growing more crops from fewer resources.